Does coordinated in-hospital product ordering and management need to be implemented from 2 May 2016? Coordinated in-hospital product ordering and management will be implemented as a phased approach, with the expectation that it will be fully effective for the introduction of BloodSTAR in December 2016. BloodSTAR is a national immunoglobulin product ordering and outcomes database which is currently in development. (Refer to Q22 & 23 for further information regarding BloodSTAR) Before BloodSTAR is implemented, it is important to prepare dispensers for the changes that will be introduced with implementation of BloodSTAR, as it will only be Dispensers who will have access to BloodSTAR information through BloodNet for the purposes of ordering product for use by authorised patients. The Australian Red Cross Blood Service will liaise with facilities to assist with implementation of the required changes. Will coordinated in-hospital product ordering and management affect current laboratory arrangements for product ordering in my hospital? If a hospital laboratory is currently ordering immunoglobulin product as stock orders, or as patient specific orders, based on clinical demand for authorised patients, these arrangements will remain unchanged at the current time. Do product orders have to be submitted through BloodNet from 2 May? Ideally, product orders will be submitted by the Dispenser through BloodNet. Where BloodNet is not available and/or alternate arrangements are in place then these can continue. However, during the transition period before BloodSTAR goes live, Weekly Order Sheets prepared by the wards should begin to be sent to the Dispenser, to improve visibility of product demand and management. This is to ensure that current inventory holdings are taken into consideration before more product is ordered, to reduce stock-piling and wastage. It is important that Dispensers are prepared in advance for the changes that will be introduced with implementation of BloodSTAR in late 2016, as it will only be Dispensers who will have access to BloodSTAR for the purposes of ordering product. BloodSTAR is a national immunoglobulin product authorisation and outcomes database which is currently in development. (Refer to Q22 & 23 for information regarding BloodSTAR)
Does coordinated in-hospital product ordering and management need to be implemented from 2 May 2016? Coordinated in-hospital product ordering and management will be implemented as a phased approach, with the expectation that it will be fully effective for the introduction of BloodSTAR in December 2016. BloodSTAR is a national immunoglobulin product ordering and outcomes database which is currently in development. (Refer to Q22 & 23 for further information regarding BloodSTAR) Before BloodSTAR is implemented, it is important to prepare dispensers for the changes that will be introduced with implementation of BloodSTAR, as it will only be Dispensers who will have access to BloodSTAR information through BloodNet for the purposes of ordering product for use by authorised patients. The Australian Red Cross Blood Service will liaise with facilities to assist with implementation of the required changes. Will coordinated in-hospital product ordering and management affect current laboratory arrangements for product ordering in my hospital? If a hospital laboratory is currently ordering immunoglobulin product as stock orders, or as patient specific orders, based on clinical demand for authorised patients, these arrangements will remain unchanged at the current time. Do product orders have to be submitted through BloodNet from 2 May? Ideally, product orders will be submitted by the Dispenser through BloodNet. Where BloodNet is not available and/or alternate arrangements are in place then these can continue. However, during the transition period before BloodSTAR goes live, Weekly Order Sheets prepared by the wards should begin to be sent to the Dispenser, to improve visibility of product demand and management. This is to ensure that current inventory holdings are taken into consideration before more product is ordered, to reduce stock-piling and wastage. It is important that Dispensers are prepared in advance for the changes that will be introduced with implementation of BloodSTAR in late 2016, as it will only be Dispensers who will have access to BloodSTAR for the purposes of ordering product. BloodSTAR is a national immunoglobulin product authorisation and outcomes database which is currently in development. (Refer to Q22 & 23 for information regarding BloodSTAR)
frequently-asked-questions-strengthen-immunoglobulinWA.docx